ARI SODIUM IODIDE(I123) 1-12 MBq DIAGNOSTIC CAPSULE Australia - English - Department of Health (Therapeutic Goods Administration)

ari sodium iodide(i123) 1-12 mbq diagnostic capsule

australian nuclear science and technology organisation t/a ansto - sodium iodide(123i), quantity: 1 mbq - capsule - excipient ingredients: dibasic sodium phosphate heptahydrate; sodium bicarbonate; sodium thiosulfate pentahydrate; sodium hydroxide; purified water; sunset yellow fcf; quinoline yellow; titanium dioxide; brilliant blue fcf; carmoisine; gelatin; ethanol; shellac; pharmaceutical glaze; carbon black - sodium iodide [123] diagnostic capsules are for diagnostic imaging of thyroid tissue.

Nithiodote Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

nithiodote solution for injection

hope pharmaceuticals ltd - sodium thiosulfate; sodium nitrite - solution for injection - 30/250 milligram(s)/millilitre - antidotes; thiosulfate; sodium nitrite

Nithiodote Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

nithiodote solution for injection

hope pharmaceuticals ltd - sodium nitrite; sodium thiosulfate - solution for injection - 30/250 milligram(s)/millilitre - antidotes; thiosulfate; sodium nitrite

SODIUM CHLORIDE 0.9 % INTRAVENOUS INFUSION BP Israel - English - Ministry of Health

sodium chloride 0.9 % intravenous infusion bp

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

SODIUM CHLORIDE 0.9 % INTRAVENOUS INFUSION BP Israel - English - Ministry of Health

sodium chloride 0.9 % intravenous infusion bp

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

Thiosulfate de Sodium Sterop 1 g/5 ml inj. sol. i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

thiosulfate de sodium sterop 1 g/5 ml inj. sol. i.v. amp.

laboratoires sterop sa-nv - sodium thiosulfate pentahydrate 1 g/5 ml - solution for injection - 1 g/5 ml - sodium thiosulfate 200 mg/ml - thiosulfate

SODIUM NITROPRUSSIDE BAXTER sodium nitroprusside 50 mg/2 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

sodium nitroprusside baxter sodium nitroprusside 50 mg/2 ml concentrated injection vial

baxter healthcare pty ltd - sodium nitroprusside, quantity: 50 mg - injection, concentrated - excipient ingredients: water for injections - sodium nitroprusside baxter concentrated injection is indicated for:,1. immediate reduction of blood pressure in patients with hypertensive crises. concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside.,2. producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate.,3. short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. patients should be commenced on oral therapy as soon as possible.

Sodium Iodide (I-131) 200MBq/mL Therapy Solution oral liquid BP vial Australia - English - Department of Health (Therapeutic Goods Administration)

sodium iodide (i-131) 200mbq/ml therapy solution oral liquid bp vial

australian nuclear science and technology organisation t/a ansto - sodium iodide(131i), quantity: 50 mbq - oral liquid, solution - excipient ingredients: sodium thiosulfate pentahydrate; water for injections; sodium bicarbonate - sodium iodide (131i) solution bp (for therapy) is indicated in the treatment of hyperthyroidism's and the detection and ablation of residual functioning thyroid tissue in differentiated thyroid carcinoma

SODIUM VALPROATE WOCKHARDT sodium valproate 1000 mg/10 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

sodium valproate wockhardt sodium valproate 1000 mg/10 ml solution for injection ampoule

wockhardt bio pty ltd - sodium valproate, quantity: 1000 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

SODIUM VALPROATE WOCKHARDT sodium valproate 400 mg/4 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

sodium valproate wockhardt sodium valproate 400 mg/4 ml solution for injection ampoule

wockhardt bio pty ltd - sodium valproate, quantity: 400 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.